Zorbtive and clostridial infection Patient Reports February 11, 2012

Zorbtive Side Effects Report #5481123-5
Zorbtive side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2007. Male patient, 41 years of age, weighting 157.0 lb, was diagnosed with short-bowel syndrome and was treated with Zorbtive. After drug was administered, patient experienced the following side effects: arthralgia, blood testosterone decreased, blood testosterone free decreased, blood thyroid stimulating hormone decreased, breast engorgement, breast tenderness, chest pain , clostridial infection, diarrhoea. Zorbtive dosage: 8.4 MG, 1 IN 1 DAYS, SUBCUTANEOUS; 6.5 MG, 1 IN 1 DAYS, SUBCUTANEOUS. During the same period patient was treated with REMICADE, HUMIRA. Patient was hospitalized. Patient recovered.

Zorbtive Side Effects Report #5542777-8
Zorbtive side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2007. Female patient, 75 years of age, was diagnosed with off label use and was treated with Zorbtive. After drug was administered, patient experienced the following side effects: clostridial infection. Zorbtive dosage: unknown. Patient was hospitalized. Patient recovered.